chr14-88615841-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_183387.3(EML5):c.5911A>G(p.Lys1971Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,611,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_183387.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual disabilityInheritance: AR Classification: LIMITED Submitted by: ClinGen
- intellectual disability, autosomal recessive 56Inheritance: AR, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EML5 | ENST00000554922.6 | c.5911A>G | p.Lys1971Glu | missense_variant | Exon 44 of 44 | 5 | NM_183387.3 | ENSP00000451998.1 | ||
| ZC3H14 | ENST00000251038.10 | c.*4090T>C | 3_prime_UTR_variant | Exon 17 of 17 | 1 | NM_024824.5 | ENSP00000251038.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000408 AC: 1AN: 245244 AF XY: 0.00000753 show subpopulations
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459564Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 725692 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5911A>G (p.K1971E) alteration is located in exon 44 (coding exon 44) of the EML5 gene. This alteration results from a A to G substitution at nucleotide position 5911, causing the lysine (K) at amino acid position 1971 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at